These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 8705996

  • 1. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
    Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D.
    Cancer Res; 1996 Aug 15; 56(16):3630-3. PubMed ID: 8705996
    [Abstract] [Full Text] [Related]

  • 2. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 15; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 3. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB.
    Cancer Res; 1995 Oct 15; 55(20):4525-30. PubMed ID: 7553621
    [Abstract] [Full Text] [Related]

  • 5. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 15; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 6. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 15; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E.
    Oncogene; 1998 Jan 29; 16(4):497-504. PubMed ID: 9484839
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT.
    Oncogene; 2002 Jun 20; 21(27):4231-6. PubMed ID: 12082610
    [Abstract] [Full Text] [Related]

  • 13. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
    Grüttgen A, Reichenzeller M, Jünger M, Schlien S, Affolter A, Bosch FX.
    J Pathol; 2001 Jul 20; 194(3):311-7. PubMed ID: 11439363
    [Abstract] [Full Text] [Related]

  • 14. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 16. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
    Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG.
    Oncogene; 1997 Feb 20; 14(7):811-8. PubMed ID: 9047388
    [Abstract] [Full Text] [Related]

  • 17. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
    Liew CT, Li HM, Lo KW, Leow CK, Chan JY, Hin LY, Lau WY, Lai PB, Lim BK, Huang J, Leung WT, Wu S, Lee JC.
    Oncogene; 1999 Jan 21; 18(3):789-95. PubMed ID: 9989830
    [Abstract] [Full Text] [Related]

  • 18. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 19. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK, Zanation AM, Moss JR, Yarbrough WG.
    Laryngoscope; 2002 Sep 15; 112(9):1587-93. PubMed ID: 12352668
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar 15; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.